Visit https://www.peervoice.com/KXS860 to view the entire programme with slides. After completing “The Heart of the Matter: An In-Depth Look at the Latest Evidence With CLL Therapies and How to Optimize Treatment Safety”, participants will be able to: Discuss the available long-term data with frontline CLL therapies, with a focus on safety considerations; and Summarize strategies to mitigate and manage key adverse effects with CLL therapies to optimize patient outcomes.